Author: chc

Richard Myer: A HCP's Response to the PLoS Study That Pharma Marketing Increases Rx's

Two_Timely-bg

Commercial Support for CME May Rise in Response to Health Care Reform

Lilly - Featured Post Background

Required Reading: Lilly Issues 52-Page Report on Value of Medicine

Epstein - Featured Post Background

Coalition Supports FDA Revision of Patient Information Requirements

New York Times Provides an Analysis of Why Pharmaceutical Companies Should Not Be Barred From Participating in CME

Associations React to NIH-Proposed Conflict of Interest Rules

Digitas: FDA Warning to Novartis Over Facebook Post Contains Upside

Europe Beating U.S. Hands Down in Oncology

Prevention Magazine's 13th Annual Consumer Survey